Global Swab and Viral Transport Medium Market Size, Trends & Growth Opportunity, By Swab Type (Oropharyngeal Swabs, Nasopharyngeal Swabs, and Others) By Application (Diagnosis of Certain Viral Infections, and Preclinical Testing), By Region and Forecast till 2027.
Report ID : IR1001147 | Industries : Healthcare | Published On :May 2024 | Page Count : 145
Global Swab and Viral Transport Medium Market Size, Trends & Growth Opportunity, By Swab Type (Oropharyngeal Swabs, Nasopharyngeal Swabs, and Others) By Application (Diagnosis of Certain Viral Infections, and Preclinical Testing), By Region and Forecast till 2027.
Global Swab and Viral Transport Medium Market
The Global Swab and Viral Transport Medium Market is expected to grow from US$ 2.4 Billion in 2021 to US$ 5.6 Billion by 2027; it is estimated to grow at a CAGR of 15.17% from 2022 to 2027.
Market Overview
Swab and viral transport medium is defined as collection and transport system which is used for the transport, collection, and long term freezing of clinical samples containing viruses such as COVID-19, mycoplasma, ureaplasma organism, and Chlamydia.
Market Drivers
Rise in demand for swabs and viral transport medium due to COVID-19 pandemic is the key driving factor which is expected to significantly boost the global swab and viral transport medium market growth. Furthermore, increase in use of viral transport medium in microbiology laboratories as well as diagnostic laboratories will have the positive impact on market growth. Moreover, increase in investments in diagnostic kits, equipments, and accessories expected to drive the market growth during this forecast period. Also, increase in geriatric population and adoption of diagnostic tests will fuel the market growth.
Market Restraints
However, less healthcare expenditures in developing countries as well as irregular distribution of medical services are the major challenging factors which are expected to hamper the global swab and viral transport medium market growth.
Impact of Covid-19
Infectious disease COVID-19 was first discovered in the Chinese city of Wuhan in the Hubei region in late December. SARS-CoV-2, a virus that causes the severe acute respiratory syndrome, spreads from person to person and is extremely infectious. The disease has spread to nearly 213 nations since its outbreak in December 2019, prompting the World Health Organization to declare a public health emergency on March 11, 2020. However, COVID-19 has interrupted the supply chain of the raw materials needed to produce swabs and viral transport medium in many nations. Additionally, as diagnostic kit producers have slowed down their output as a result of the pandemic, the market development for diagnostic products is declining.
Market Segmentation
Segmentation By Swab Type: Global Swab and Viral Transport Medium Market is segmented into swab type such as Oropharyngeal Swabs, Nasopharyngeal Swabs, and Others.
Segmentation By Application: Global Swab and Viral Transport Medium Market is segmented into application such as Diagnosis of Certain Viral Infections, and Preclinical Testing.
Segmentation By End-User: Global Swab and Viral Transport Medium Market is segmented into end user such as Diagnostic Laboratories, Microbiology Laboratories, and Others.
Segmentation By Region: Global Swab and Viral Transport Medium Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The pandemic in North America resulted in a large number of laboratory samples, which fueled market expansion. On the other hand, the region's market is growing significantly due to the presence of biopharma companies, a large number of laboratories, well-developed healthcare services, and research studies on viral infection.
Market Key Players
Various key players are discussed in this report such as Thermo Fisher Scientific, Puritan Medical Products, BD, Laboratory Corporation of America, Safegaurd DNA Diagnostics, Inc, Microbix Biosystems Inc., Hardy Diagnostics, VIRCELL, HiMedia Laboratories, MWE, and Starplex Scientific.
Industrial Development
• One of the biggest chains of infectious disease laboratories in the Philippines, Safegaurd DNA Diagnostics, Inc., introduced COVID sample collection using the Rhinostics, dry nasal, and Nasopharyngeal collection swabs in June 2021.
• The commercial release of Microbix Biosystems Inc.'s viral transport medium to support Canadian RT-PCR testing for the COVID-19 disease was revealed in February 2021. Microbix Biosystems Inc. is a life science innovator and exporter.
Market Taxonomy
By Swab Type
• Oropharyngeal Swabs
• Nasopharyngeal Swabs
• Others
By Application
• Diagnosis of Certain Viral Infections
• Preclinical Testing
By End User
• Diagnostic Laboratories
• Microbiology Laboratories
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Swab and Viral Transport Medium Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?
Global Swab and Viral Transport Medium Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Swab and Viral Transport Medium Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Swab and Viral Transport Medium Market, By Swab Type
5.1 Y-o-Y Growth Comparison, By Swab Type
5.2 Global Swab and Viral Transport Medium Market Share Analysis, By Swab Type
5.3 Global Swab and Viral Transport Medium Market Size and Forecast, By Swab Type
5.3.1Oropharylgeal Swabs
5.3.2 Nasopharyngeal Swabs
5.3.3Others
6 Global Swab and Viral Transport Medium Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Swab and Viral Transport Medium Market Share Analysis, By Application
6.3 Global Swab and Viral Transport Medium Market Size and Forecast, By Application
6.3.1 Diagnosis of Certain Viral Infections
6.3.2 Preclinical Testing
7 Global Swab and Viral Transport Medium Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Swab and Viral Transport Medium Market Share Analysis, By End User
7.3 Global Swab and Viral Transport Medium Market Size and Forecast, By End User
7.3. 1 Diagnostic Laboratories
7.3.2 Microbiology Laboratories
7.3.3Others
8 Global Swab and Viral Transport Medium Market, By Region
8.1 Global Swab and Viral Transport Medium Market Share Analysis, By Region
8.2 Global Swab and Viral Transport Medium Market Share Analysis, By Region
8.3 Global Swab and Viral Transport Medium Market Size and Forecast, By Region
9 North America Swab and Viral Transport Medium Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 North America Swab and Viral Transport Medium Market Share Analysis, By Swab Type
9.3 North America Swab and Viral Transport Medium Market Size and Forecast, By Application
9.4 North America Swab and Viral Transport Medium Market Size and Forecast, By End User
9.5 North America Swab and Viral Transport Medium Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Swab and Viral Transport Medium Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Europe Swab and Viral Transport Medium Market Share Analysis, By Swab Type
10.3 Europe Swab and Viral Transport Medium Market Size and Forecast, By Application
10.4 Europe Swab and Viral Transport Medium Market Size and Forecast, By End User
10.5 Europe Swab and Viral Transport Medium Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Swab and Viral Transport Medium Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Asia Pacific Swab and Viral Transport Medium Market Share Analysis, By Swab Type
11.3 Asia Pacific Swab and Viral Transport Medium Market Size and Forecast, By Application
11.4 Asia Pacific Swab and Viral Transport Medium Market Size and Forecast, By End User
11.5 Asia Pacific Swab and Viral Transport Medium Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Swab and Viral Transport Medium Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Latin America Swab and Viral Transport Medium Market Share Analysis, By Swab Type
12.3 Latin America Swab and Viral Transport Medium Market Size and Forecast, By Application
12.4 Latin America Swab and Viral Transport Medium Market Size and Forecast, By End User
12.5 Latin America Swab and Viral Transport Medium Market Size and Forecast, Country
13 Middle East Swab and Viral Transport Medium Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Middle East Swab and Viral Transport Medium Market Share Analysis, By Swab Type
13.3 Middle East Swab and Viral Transport Medium Market Size and Forecast, By Application
13.4 Middle East Swab and Viral Transport Medium Market Size and Forecast, By End User
13.5 Middle East Swab and Viral Transport Medium Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Thermo Fisher Scientific
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Puritan Medical Products
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 BD
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Laboratory Corporation of America
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Hardy Diagnostics
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 VIRCELL
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 HiMedia Laboratories
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 MWE
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Starplex Scientific
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies